BHST NASDAQ
BioHarvest Sciences Inc.
1W: -0.7%
1M: -23.7%
3M: -49.8%
YTD: -72.2%
1Y: -84.3%
$1.47
-0.02 (-1.34%)
Weekly Expected Move ±6.0%
$1
$1
$1
$2
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$25.5M
52W Range1.42-12.8
Volume19,585
Avg Volume45,014
Beta1.38
Dividend—
Analyst Ratings
Company Info
CEOZaki Rakib
Employees89
SectorIndustrials
IndustryAgricultural - Commodities/Milling
IPO Date2021-01-08
Websitebioharvest.com
1140-625 Howe Street
Vancouver, BC V6C 2T6
CA
Vancouver, BC V6C 2T6
CA
(604) 622-1186
About BioHarvest Sciences Inc.
BioHarvest Sciences Inc. is a biotechnology company that operates through two segments: Products and CDMO Services. The company has developed a botanical synthesis platform technology to grow plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, and sale of science-based health and wellness nutraceutical solutions, as well as offering Contract Development and Manufacturing Operation (CDMO) services to third parties in the pharmaceutical, cosmeceutical, and nutrition industries.
Latest News
BioHarvest Sciences sets share repurchase plan
BioHarvest Sciences (BHST) Q2 2026 Earnings Call Transcript
BioHarvest Sciences Inc. Common Stock Q2 2026 Earnings Call Summary
BioHarvest Sciences Inc. (BHST) Reports Q2 Loss, Lags Revenue Estimates
Celldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates
Recent Insider Trades
No insider trades found